Markets

PartnerIssuerCoverage

MedTech Innovator Inspira Advances AI-Powered Blood Monitoring Technology as Clinical Results Near
Wall Street Wire

MedTech Innovator Inspira Advances AI-Powered Blood Monitoring Technology as Clinical Results Near

In a landscape where medical technology increasingly intersects with artificial intelligence, Inspira Technologies (NASDAQ: IINN*) has announced a significant advancement in its blood monitoring platform. The Israeli medical device company has integrated a new oxygenation indicator into its AI-powered HYLA blood sensor, potentially eliminating the need for repeated blood

Actelis adds former Alcatel Corporate CTO & Celestea Capital Parter to Board
Wall Street Wire

Actelis adds former Alcatel Corporate CTO & Celestea Capital Parter to Board

Actelis Networks* (NASDAQ: ASNS), a provider of cyber-hardened networking solutions, has appointed Dr. Niel Ransom to its Board of Directors, bringing in a veteran with a strong background in network security, telecommunications, and deep-tech investments. His extensive experience in developing and scaling secure communications infrastructure is expected to

Market Leaders: Silexion’s Ilan Hadar Discusses Preclinical Milestones in KRAS-Driven Cancer Treatment, Market Momentum and Financing
Wall Street Wire

Market Leaders: Silexion’s Ilan Hadar Discusses Preclinical Milestones in KRAS-Driven Cancer Treatment, Market Momentum and Financing

Silexion Therapeutics* (NASDAQ: SLXN) is making strides in oncology with its RNAi-based treatment, SIL-204, targeting KRAS-driven cancers. In an interview on Market Leaders, CEO Ilan Hadar discussed the company’s recent breakthroughs and market activity. During the interview, Hadar highlighted that SIL-204 has shown promising preclinical